Markets
BSE See NSE See 39,046.34
85.55 (0.22%)
collapse Related Readings collapse

Havells India: Recommendation Review

| 2/9/2012 9:30 PM Thursday

We had recommended Havells India in DSIJ Vol. 26, Issue No. 9 (dated April 11-24, 2011), when the scrip was trading at Rs 386. Our recommendation was backed by expectations of better growth from the electrical consumer durables segment and the switch gear segment. The major factor, though, was the better performance of Sylvania. A drag on the company’s consolidated performance for quite some time, it was expected to turn around. We reviewed the scrip again in DSIJ Vol. 26, Issue No. 22 (dated October 10-23, 2011), when it was trading at Rs 354. At that time, despite the fact that the scrip was trading below the recommended levels, we had asked our readers to hold onto it.

After a good financial performance in Q3 FY12, the scrip has witnessed an upmove and is trading at Rs 485. In Q3 FY12, the consolidated revenues were up by 16 per cent to Rs 1660 crore and the EBITDA also increased by 38 per cent to Rs 176 crore. As expected, the electrical consumer durables segment has been a major revenue driver. The cash flow at the end of 9M FY12 stood at Rs 78.90 crore. The capex for 9M FY12 stood at Rs 98 crore. The company’s total debt as on 31st December, 2011 has reduced to Rs 87 crore from Rs 151.30 crore in December 2010.

Currently, the scrip is trading at Rs 500. As it has achieved the target, we feel that booking profits seems like a prudent strategy.

 

Find More Articles on: DSIJ Magazine, Reviews, Stock Recommendations, Fundamental Picks

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

MIDHANI and HAL partner to develop bio implants

Geyatee Deshpande / Article rating: 5.0

Mishra Dhatu Nigam Limited (MIDHANI) signs an MoU with Hindustan Antibiotics Limited (HAL). This MoU will provide synergy for quality manufacturing of MIDHANI’s Bio-medical Implants and get access to the pan-India distribution of HAL. This partnership is aimed to gain advantage from the strengths of both the companies and benefit users of Bio-medical products in India.

12345678910Last

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Logistics sector will play a vital role in making the concept of ‘Make in India’ a success. This will be further aided by some of the recent steps taken by Government of India such as granting of infra sector status to logistics sector.

Best and worst Performing Sector Funds of Year 2017

Best and worst Performing Sector Funds of Year 2017

As the year-end has approached most of you are eager to know the mutual fund movers and shakers of the year 2017. Read on to find the performance of various sector dedicated funds.

Markets may start positive, but volatility likely due to F&O expiry

Markets may start positive, but volatility likely due to F&O expiry

The start of the F&O expiry day is likely to be in the green, but volatility may creep in with the progress of the session. The SGX Nifty suggests that the Nifty could open at 10,525 with gains of 32 points at the opening bell. 

Pidilite announces buyback of Rs 500 crore

Pidilite announces buyback of Rs 500 crore

The buyback offer comprises purchase of up to 50,00,000 equity shares. The buyback offer size comprises 0.975 per cent of the total paid-up equity capital of the company.

Bank Nifty drags markets to close in the red

Bank Nifty drags markets to close in the red

The late session fall in Bank Nifty changed the direction of the market, leading to a marginal fall in the benchmark indices. Bank Nifty yet again resisted at its multiple point downward sloping trendline level at 25733.

Six major underperforming MF schemes having higher expense ratios

Six major underperforming MF schemes having higher expense ratios

Mutual funds with a large size of assets under management (AUMs) are supposed to have lower expense ratios. However, there are schemes with large AUMs but having higher expense ratios and generating lower returns. 

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma index has come in as the healer in an otherwise sluggish market. Index has given a consolidation breakout at the 9420 level today and if the it sustains 9420, followed by 9628 on the upside, it has a long way to go.

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.35 p.m. on December 27.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on December 27 opened gap down. BSE Sensex is trading at 34,068.15, up by 57.54 points and the Nifty is trading at 10,539.45, up by 7.95 points.

Five stocks with selling interest

Five stocks with selling interest

Overall volumes in futures & options currently stand at 62.75 lakh contracts with a turnover of Rs. 5,19,204.72 crore.